Cargando…
Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patients
Linezolid is now recommended as a first line drug for Multidrug Resistant Tuberculosis (MDR-TB). Previous studies reported hematologic toxicity as one of the main side effects. The mechanism of this toxicity is mitochondrial dysfunction, for which a biomarker is Growth differentiation factor-15 (GDF...
Autores principales: | Oehadian, Amaylia, Santoso, Prayudi, Menzies, Dick, Ruslami, Rovina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358446/ https://www.ncbi.nlm.nih.gov/pubmed/35957807 http://dx.doi.org/10.1016/j.idcr.2022.e01591 |
Ejemplares similares
-
Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
por: Oehadian, Amaylia, et al.
Publicado: (2022) -
Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parameters
por: Annisa, Nurul, et al.
Publicado: (2022) -
Analytical and Clinical Validation of Assays for Volumetric Absorptive Microsampling (VAMS) of Drugs in Different Blood Matrices: A Literature Review
por: Nugraha, Rhea Veda, et al.
Publicado: (2023) -
Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
por: Du, Jian, et al.
Publicado: (2021) -
The detection of Howell-Jolly body-like inclusions in a case of coronavirus disease-2019 (COVID-19)
por: Alisjahbana, Bachti, et al.
Publicado: (2020)